Siemens Healthineers eBlast
Web version

50° Wide-Angle Tomosynthesis ready for screening

With FDA-approved Insight 2D

A majority of breast care professionals have gained most of their expertise reading 2D mammography. With tomosynthesis growing into the screening environment, we aim to ease the transition from 2D to tomosynthesis with Insight 2D. Insight 2D enables fast prior comparison and intuitive breast density assessment1,2. Insight 2D is now FDA approved for diagnosis in combination with tomosynthesis.
Can you tell the difference?

Shaping the future of tomosynthesis in screening

At Siemens Healthineers, we believe that tomosynthesis will dominate the screening space in the near future. And we are convinced that 50° Wide-Angle Tomosynthesis is the superior method for cancer detection3. It provides the highest mass detectability4, increasing your diagnostic accuracy. Not only do we enable superior cancer detection3 with our 50° Wide-Angle Tomosynthesis, but we also deliver a patient-centric solution – with decreased compression and the right dose.

Get the proof
Click here
Click here

The angle makes the difference

The tomosynthesis angular range has an impact on mass conspicuity in patients with dense breasts. How does the angle affect breast structural noise or lesion detectability in digital breast tomosynthesis? Prof. Wei Zhao, PhD, from Stony Brook in New York, had a closer look at the physics behind the angle and studied how it affects the depiction of lesions in dense breast tissue. Watch her present the initial study results!

Watch the video

Learn more about the future of Breast Imaging

Being a trusted partner of our customers, Siemens Healthineers would like to support you with online education offerings. Watch our videos with inspiring clinical lectures about the latest developments in breast care. Refresh your professional knowledge and watch the recordings of clinical talks and symposia featuring leading worldwide experts in breast imaging.

Watch our breast imaging recordings
Click here
1) Talk of Prof. Van Ongeval at Breast Care Day 2019, Vienna:
2) Data on file
3) Zackrisson S, Lång K, Rosso A, Johnson K, Dustler M, Förnvik D et al. (2018) One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): A prospective, population-based, diagnostic accuracy study. The Lancet Oncology. doi:10.1016/S1470-2045(18)30521-7.
4) David A. Scaduto, Hailiang Huang, Chunling Liu, Kim Rinaldi, Axel Hebecker, Thomas Mertelmeier, Sebastian Vogt, Paul Fisher, Wei Zhao, "Impact of angular range of digital breast tomosynthesis on mass detection in dense breasts," Proc. SPIE10718, 14th International Workshop on Breast Imaging (IWBI 2018), 107181V (6 July 2018); doi: 10.1117/12.2318243

The products/features and/or service offerings (mentioned herein) are not commercially available in all countries and/or for all modalities. Their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
Twitter Icon   Facebook Icon   Instagram Icon   LinkedIn Icon   YouTube Icon
Contact Us | Privacy Policy
This email was sent by:
Siemens Healthcare GmbH | Henkestr. 127, 91052 Erlangen, Germany
Information for healthcare professionals. The Siemens Healthineers newsletter and websites, including but not limited to and its affiliated sites, provide an online resource for healthcare professionals
 Do not reply to this email as it was sent from an unmonitored account.
Unsubscribe from the Breaking News.
Reset your password.
Contact support. Privacy Policy
Email sent to: ., 1350 North Kolb Road, Suite 215, Tucson, AZ 85715 USA
+1 520-298-1000